Skip to main content
Tech.euFundingExplorerBeta

ZOE

ZOE analyzes your unique gut, blood fat and blood sugar responses. So you can take back control of your health & weight

ZOE has raised €45M across 4 funding rounds from 7 investors, most recently a Series B round in Jul 2024. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€45M
€45,394,410
Funding rounds
4
Investors
7
distinct backers
Active since
2021-12
latest 2024-07

Funding by year

EUR raised per year
ZOE — funding by year — interactive chart.
Data table
ZOE — funding by year
2021€0
2022€29M
2023€2.4M
2024€14M

Signals

High confidence
Raise-next likelihood48
base rate 48% for Series B
  • ▼ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▲ 5y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2024-07-30Series B€14MCoefficient CapitalView deal →
2023-03-15Other€2.4MFlight FundView deal →
2022-12-01Other€29MAccomplice,Ahren,Balderton Capital,Daphni,L CattertonView deal →
2021-12-23Series B—Balderton CapitalView deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData